Moneycontrol
Get App
SENSEX NIFTY
you are here:

Lasa Supergenerics Ltd.

BSE: 540702 | NSE: LASA |

Shares falling in the `Trade-to-Trade` or `T-segment` are traded in this series and no intraday is allowed. This means trades can only be settled by accepting or giving the delivery of shares.
Series: BE | ISIN: INE670X01014 | SECTOR: Miscellaneous

Success
Alert
Please select a Day.
Info

BSE Live

Feb 18, 12:22
39.20 -2.05 (-4.97%)
Volume
AVERAGE VOLUME
5-Day
32,865
10-Day
37,743
30-Day
23,936
3,737
  • Prev. Close

    41.25

  • Open Price

    39.40

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    39.20 (1341)

NSE Live

Feb 18, 12:36
39.20 -2.05 (-4.97%)
Volume
AVERAGE VOLUME
5-Day
89,588
10-Day
65,295
30-Day
49,306
9,563
  • Prev. Close

    41.25

  • Open Price

    39.35

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    39.20 (7321)

ANNOUNCEMENTS ON Lasa Supergener

  • Feb 11, 2020 14:40 Source: BSE

    Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    Press Release Lasa Supergenerics Ltd

  • Feb 11, 2020 14:26 Source: BSE

    Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 47 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, please find enclosed herewith copies of newspaper advertisements in the following newspaper: 1. Business Standard on February 11,2020 2. Mumbai Lakhsdeep on February 11,2020

  • Feb 10, 2020 16:38 Source: NSE

    Lasa Supergenerics Limited

    Lasa Supergenerics Limited has informed the Exchange regarding Outcome of Board Meeting held on February 10, 2020.which was commenced at 1.00 p.m. and concluded at 3.45 p.m. have considered, approved and took on record the Unaudited Financial Results for the quarter and nine months ended December 31,2019.

  • Feb 10, 2020 16:07 Source: BSE

    Lasa Supergenerics - Financial Results For The Quarter Ended December 31,2019

    The Board of Directors in their meeting held today at the Corporate Office of the Company have considered, approved and took on record the Unaudited Financial Results for the quarter and nine months ended December 31,2019.

  • Feb 03, 2020 15:11 Source: BSE

    Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to provisions of Regulation 47(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith, copies of the newspaper advertisements in respect of Board Meeting, scheduled to be held on Monday, February 10, 2020 and published in the following Newspapers 1. Business Standard on February 2, 2020; and 2. Mumbai Lakshdeep on February 2, 2020.

  • Feb 01, 2020 14:51 Source: BSE

    Lasa Supergenerics - Board Meeting Intimation for Quarterly Results For The Quarter Ended December 31, 2019

    Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2020 ,inter alia, to consider and approve and take on record Unaudited Financial Results of the Company along with Limited Review Report for the quarter ended December 31, 2019

  • Jan 22, 2020 12:13 Source: NSE

    Lasa Supergenerics Limited

    Lasa Supergenerics Limited has informed the Exchange regarding ''Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2019 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company''.

  • Jan 22, 2020 11:26 Source: BSE

    Lasa Supergenerics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2019 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company

  • Jan 18, 2020 16:08 Source: BSE

    Lasa Supergenerics - Shareholding for the Period Ended December 31, 2019

    Lasa Supergenerics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here

  • Jan 13, 2020 11:03 Source: BSE

    Lasa Supergenerics - Clarification

    With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Lasa Supergenerics Ltd has submitted to BSE a copy of Clarification is enclosed.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Feb 10, 2020
Remark : Quarterly Results